ARTICLE | Company News
Myogen, BASF deal
January 2, 2001 8:00 AM UTC
Myogen will collaborate with BF's BASF Pharma business to develop BSF 208075, a type-A selective endothelin receptor antagonist, to treat several cardiovascular indications. BASF Pharma has completed ...